Health Condition 1: F411- Generalized anxiety disorder
Conditions
Interventions
None listed
Sponsors
EVIMED SOLUTION
Eligibility
Inclusion criteria
Inclusion criteria: Clinically diagnosed anxiety disorder. Willingness to comply with study requirements and follow instructions. Absence of significant cognitive impairment or comorbid psychiatric disorders. Ability to provide informed consent. Stable medication regimen for other medical conditions for at least 4 weeks prior to the
Exclusion criteria
Exclusion criteria: Individuals with known allergies to the contents of Drug. Pregnant or breastfeeding women. Individuals with associated comorbidities Recent participation in another clinical trial. Presence of severe medical conditions or unstable psychiatric disorders. Current substance abuse or dependence. Use of medications known to interact with the study drug Significant medical illness or unstable medical condition. Use of other anxiolytic medications within the past 4 weeks. Inability to comprehend or effectively communicate in the primary language of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| effectiveness of treatments in reducing symptoms mentioned in GAD scale.Timepoint: effectiveness of treatments in reducing symptoms mentioned in GAD scale in one month. | — |
Secondary
| Measure | Time frame |
|---|---|
| Monitoring for adverse effects such as Exacerbation of anxiety symptomsTimepoint: Monitoring for adverse effects such as Exacerbation of anxiety symptoms done during follow up 10th, 20th and 30th day of treatment | — |
Countries
India
Contacts
Public ContactDr Yogini M Bhoyar
Dr D Y Patil College of Ayurveda and Research Centre
Outcome results
None listed